Imeglimin Hydrochloride Tablets 500 MG – IGLYN 500 Tablets

IGLYN 500 Tablets
Composition:- Imeglimin Hydrochloride 500 mg

IGLYN 500 Tablets – Imeglimin Hydrochloride Tablets 500 MG is a first-in-class Glimin oral antidiabetic medication, specifically formulated for treating Type 2 diabetes mellitus. It works by a dual mechanism of action, enhancing insulin secretion and promoting insulin sensitivity, making it a unique glin-class agent. Improving mitochondrial function in the liver and muscle ensures balanced glycemic control with minimal side effects. Imeglimin can be prescribed both as monotherapy and in combination therapy with other antidiabetic agents.

Key Points of Imeglimin Hydrochloride 500 mg – IGLYN 500 Tablets

• First-in-Class Glimin Derivative – As it is unique in class and action, it works across liver, muscle, and pancreatic tissues to reduce glucose output and improve glucose uptake.
• Dual Targeted Action – Enhances β-cell activity and insulin sensitivity while optimizing mitochondrial bioenergetics.
• Safe & Well-Tolerated – Low risk of hypoglycemia, no major weight gain, suitable for early-stage therapy and long-term use.

Can be Prescribed by:

• Diabetologists & Endocrinologists
• General Physicians
• Healthcare practitioner

Disclaimer: To be used under medical supervision only. Not intended for general public promotion. This content is meant for registered healthcare professionals only.